QureTech Bio Appoints Three New Board Members to Strengthen Drug and Business Development
QureTech Bio AB (QTB), a pharmaceutical development company originating from Umeå University, proudly announces the appointment of three new board members at its Annual General Meeting held on May 25, 2023. This strategic move is aimed at further enhancing QTB's drug and business development.
The newly appointed board members are:
Yijing Sun Hultgren
Yijing has over a decade of experience